Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia
Adelheid Kratzer(Deutsches Herzzentrum der Charité), Dagmar Kratky(BioTechMed-Graz), Branislav Radović(Charité - Universitätsmedizin Berlin), Gerhard M. Kostner(Medical University of Graz), Shinobu Miyazaki‐Anzai(University of Colorado Denver), Emine Calayir(Medical University of Graz), Nora Rathke(Medical University of Graz), Makoto Miyazaki(Chiba Cancer Center), Sanja Levak‐Frank(University of Graz), Birgit Ebner(Medical University of Graz), Helmut Ahammer(Medical University of Graz), Tatjana Becker(Medical University of Graz), Uday B. Kompella, Gerald Höefler(Medical University of Graz), Thomas Pfeifer(Medical University of Graz), Michael Trauner(Medical University of Vienna), Georg Uray(University of Graz), Rajendra S. Kadam(Denver Health Medical Center), Prakash G. Chandak(Medical University of Graz), Moshe Levi(Georgetown University), Guenter Fauler(Medical University of Graz), Marlene Buchebner(Medical University of Graz)
Cited by 140
Related Papers
Triglycerides and Cardiovascular Disease
|Circulation|2011|1.9k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Lipid Rafts Reconstituted in Model Membranes
|Biophysical Journal|2001|1.4k
Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity
|Proceedings of the National Academy of Sciences|2002|1.1k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k